transdermal patch

(redirected from Transdermal Drug Delivery System)
Also found in: Thesaurus, Medical, Encyclopedia.

transdermal patch

n.
A medicated adhesive pad that is placed on the skin to deliver a timed-release dose of medication through the skin into the bloodstream. Also called skin patch.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.transdermal patch - a medicated adhesive pad placed on the skin for absorption of a time released dose of medication into the bloodstreamtransdermal patch - a medicated adhesive pad placed on the skin for absorption of a time released dose of medication into the bloodstream
estradiol patch - a transdermal patch that allows estradiol to be absorbed into the blood stream; used in treating estrogen deficiency and in hormone replacement therapy
pad - a flat mass of soft material used for protection, stuffing, or comfort
References in periodicals archive ?
Hisamitsu Pharmaceutical, founded in 1847, has specialized in transdermal drug delivery system technology to relieve everyday aches and pains since it introduced its Salonpas The of patches in 1934.
Development of a cGMP manufacturing process for a polymeric microneedle transdermal drug delivery system.
Among their topics are myth and science regarding laser and light therapy for acne, emerging trends in the diagnosis and management of atopic dermatitis, which side mitogen-activated protein kinases and their inhibitors are on in the fight against psoriasis, dendritic cell immunotherapy for treating malignant melanoma, malignant melanoma in ethnic skin, a novel transdermal drug delivery system mediated by arginine-rich intracellular delivery peptides, and onychomysosis caused by non-dermatophytic filamentous fungi.
an emerging international pharmaceutical and medical company, is developing 1) innovative topical formulations based on the NexACT transdermal drug delivery system, including the Alprox-TD and Femprox creams for treating male and female sexual dysfunction; and 2) Viratrol, a non-invasive, hand-held device for treating oral and genital herpes.
US transdermal drug delivery system developer Vyteris (OTCBB:VYTR) on Monday said it had concluded the acquisition of MediSync BioServices, as it looks to step up its growth strategy.
BioChemics is a pharmaceutical company that has developed a novel, transdermal drug delivery system for the first time that may allow almost any drug to be efficiently delivered through the skin.
BioChemics is a specialty pharmaceutical company that has developed a novel, transdermal drug delivery system called VALE[R] (Vaso-active Lipid Encapsulated) that for the first time may allow almost any drug to be efficiently delivered through the skin.
OTCBB: VYTR), manufacturer of the first FDA-approved active patch transdermal drug delivery system and a leader in active transdermal drug delivery technology, announced the formation of a Scientific Advisory Group comprised of four renowned scientists, researchers and clinicians with diverse expertise in active transdermal drug and peptide delivery and central nervous system disorders.